Solid Biosciences (SLDB) Cash & Equivalents Growth (5y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05% |
| Dec 31, 2025 | -17.32% |
| Sep 30, 2025 | 19.87% |
| Jun 30, 2025 | 27.79% |
| Mar 31, 2025 | 31.53% |
| Dec 31, 2024 | 1.08% |
| Sep 30, 2024 | -7.49% |
| Jun 30, 2024 | 12.94% |
| Mar 31, 2024 | 16.70% |
| Dec 31, 2023 | -3.04% |
| Sep 30, 2023 | -17.64% |
| Jun 30, 2023 | -8.92% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | 24.41% |
| Sep 30, 2022 | 26.58% |
| Jun 30, 2022 | 10.67% |
| Mar 31, 2022 | 34.69% |